Sectors
BDTX
Black Diamond Therapeutics, Inc.
1.83
31 x 1.83
17 x 1.84
bid
ask
-
0.04
1.87%
12:27 PM
timesize
| Ytd | -24.49% | |
| 1y | -42.48% |
1.81
day range
1.90
1.60
52 week range
4.94
| Open | 1.86 | Prev Close | 1.87 | Low | 1.81 | High | 1.90 | Mkt Cap | 107.15M |
| Vol | 135.73K | Avg Vol | 1.74M | EPS | -0.64 | P/E | -2.92 | Forward P/E | -1.80 |
| Beta | 3.25 | Short Ratio | 11.67 | Inst. Own | 98.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 2.13 | 200-d Avg | 2.73 | 1yr Est | 14.50 |
| Income Statement | |||
| Operating Expenses | 11.26M | ||
| Research and Development Expense | 7.00M | ||
| Selling, General and Administrative Expense | 4.26M | ||
| Operating Income | -11.26M | ||
| Net Income | -9.04M | ||
| Net Income Common Stock | -9.04M | ||
| Net Income Common Stock (USD) | -9.04M | ||
| Consolidated Income | -9.04M | ||
| Earnings per Basic Share | -0.16 | ||
| Earnings per Basic Share (USD) | -0.16 | ||
| Earnings per Diluted Share | -0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -9.04M | ||
| Earning Before Interest & Taxes (USD) | -9.04M | ||
| Weighted Average Shares | 57.23M | ||
| Weighted Average Shares Diluted | 57.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.90M | ||
| Cash and Equivalents (USD) | 30.90M | ||
| Investments | 88.19M | ||
| Investments Current | 88.19M | ||
| Current Assets | 122.97M | ||
| Property, Plant & Equipment Net | 9.10M | ||
| Total Assets | 132.92M | ||
| Total Debt | 14.09M | ||
| Current Liabilities | 14.53M | ||
| Debt Non-Current | 14.09M | ||
| Total Liabilities | 28.62M | ||
| Accumulated Retained Earnings (Deficit) | -473.78M | ||
| Accumulated Other Comprehensive Income | -36.00K | ||
| Shareholders Equity | 104.30M | ||
| Shareholders Equity (USD) | 104.30M | ||
| Assets Non-Current | 9.96M | ||
| Total Debt (USD) | 14.09M | ||
| Liabilities Non-Current | 14.09M | ||
| Trade and Non-Trade Payables | 2.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 27.00K | ||
| Net Cash Flow from Financing | -185.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.08M | ||
| Issuance (Purchase) of Equity Shares | -185.00K | ||
| Net Cash Flow from Investing | 19.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 19.50M | ||
| Net Cash Flow from Operations | -10.23M | ||
| Share Based Compensation | 1.45M | ||